Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.62 USD | +0.08% | -0.24% | +3.95% |
14/05 | Centogene, Evotec Discover New Molecule for Potential Gaucher Disease Treatment | MT |
30/04 | Evotec, Bayer to Collaborate on New Cardiovascular Disease Therapies | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+12.07% | 958.65Cr | |
-0.03% | 558.45Cr | |
+8.65% | 550.13Cr | |
+6.79% | 523.84Cr | |
+29.08% | 484.4Cr | |
+24.28% | 461.02Cr | |
+2.73% | 412.81Cr | |
+7.31% | 404.95Cr | |
-0.32% | 327.99Cr |
- Stock Market
- Equities
- EVO Stock
- News Eaton Vance Ohio Municipal Income Trust
- Deutsche Bank Downgrades Evotec SE to Hold From Buy After Weaker-Than-Expected Q3 Results, Cuts Price Target to EUR21 From EUR26